Shareholders that lost money on Lineage, Inc.(LINE) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

Shareholders that lost money on Lineage, Inc.(LINE) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More GlobeNewswire September 05, 2025 NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Lineage, Inc. (“Lineage, Inc.” or the “Company”) (NASDAQ: LINE) of a class action securities lawsuit. CLASS […]

September 30, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against NVO

September 30, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against NVO GlobeNewswire September 05, 2025 NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to

XPLR Infrastructure, LP fka NextEra Energy Partners, LP Investors: Please contact the Portnoy Law Firm to recover your losses. September 8, 2025 Deadline to file Lead Plaintiff Motion.

XPLR Infrastructure, LP fka NextEra Energy Partners, LP Investors: Please contact the Portnoy Law Firm to recover your losses. September 8, 2025 Deadline to file Lead Plaintiff Motion. GlobeNewswire September 05, 2025 Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 05, 2025 (GLOBE NEWSWIRE)

Investors SueWallSt Over Biohaven Ltd. Stock Drop – Contact Levi & Korsinsky to Join

NEW YORK, NY / ACCESS Newswire / September 5, 2025 / – SueWallSt: Class Action Filed Against Biohaven Ltd. – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between March 24, 2023 and May 14, 2025. If you suffered

RxSight, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 22, 2025 Deadline to file Lead Plaintiff Motion.

RxSight, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 22, 2025 Deadline to file Lead Plaintiff Motion. GlobeNewswire September 05, 2025 Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 05, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises

The Global PAD Association has presented the 2025 Walking As Therapy Breakthrough Research of the Year award to The STRIDE Trial Research Team led by Dr. Marc P. Bonaca

AURORA, CO / ACCESS Newswire / September 5, 2025 / The Global PAD Association has presented the 2025 Walking As Therapy Breakthrough Research of the Year award to The STRIDE Trial Research Team led by Dr. Marc P. Bonaca, Executive Director at CPC Clinical Research, for pioneering research demonstrating significant improvements in walking capacity, symptoms,

Levi & Korsinsky Notifies Shareholders of Lockheed Martin Corporation(LMT) of a Class Action Lawsuit and an Upcoming Deadline

(NYSE:LMT), NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Lockheed Martin Corporation (“Lockheed Martin Corporation” or the “Company”) (NYSE: LMT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lockheed Martin Corporation investors who were adversely affected by alleged securities

Levi & Korsinsky Notifies Shareholders of Lockheed Martin Corporation(LMT) of a Class Action Lawsuit and an Upcoming Deadline

Levi & Korsinsky Notifies Shareholders of Lockheed Martin Corporation(LMT) of a Class Action Lawsuit and an Upcoming Deadline GlobeNewswire September 05, 2025 NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Lockheed Martin Corporation (“Lockheed Martin Corporation” or the “Company”) (NYSE: LMT) of a class action securities lawsuit. CLASS

BIOVAXYS ANNOUNCES SHARE CONSOLIDATION

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (“BioVaxys” or the “Company”) announces, further to its news release dated August 27, 2025, the consolidation of its common shares (“Common Shares”) on the basis of ten (10) pre-consolidation Common Shares for one (1) post-consolidation Common Share (the “Consolidation”). https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg The Company anticipates its Common Shares

Scroll to Top